Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. ONON
2. IAUX
3. KKR
4. LLY
5. DAVA
6. MONC:IM
7. MONRY
8. NYXH
9. PNR
10. ACCV

Go back to Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape 
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 13.48 --0 (-0%)
Previous Close $13.48    52 Week High $3.65 
Open $13.48    52 Week Low $1.24 
Day High $13.48    P/E N/A 
Day Low $13.48    EPS $0.00 
Volume 50